Sirnaomics and Innovent Entered Strategic Collaboration to Conduct Clinical Oncology Studies Combining STP705 and Sintilimab in the US

GAITHERSBURG, Md. and SUZHOU, China, Jan. 7, 2020 /PRNewswire/ -- Sirnaomics Inc. ("Sirnaomics"), a leading biopharmaceutical company in discovery and development of RNAi therapeutics against cancer and fibrotic diseases, and Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a...

from PR Newswire: https://ift.tt/300ZW7Z